Geode Capital Management’s Rock Creek Pharmaceuticals RCPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
– Sell
-31,699
Closed -$25K – 4231
2015
Q3
$25K Buy
+31,699
New +$35.3K ﹤0.01% 4078
2015
Q2
– Sell
-31,665
Closed -$80K – 4048
2015
Q1
$80K Buy
31,665
+39
+0.1% +$154 ﹤0.01% 3796
2014
Q4
$143K Buy
31,626
+39
+0.1% +$205 ﹤0.01% 3702
2014
Q3
$221K Buy
31,587
+3,455
+12% +$34.1K ﹤0.01% 3540
2014
Q2
$414K Buy
+28,132
New +$488K ﹤0.01% 3240

Other funds holding RCPI

Geode Capital Management's RCPI Position: Q4 2015 in Review

Geode Capital Management sold out of Rock Creek Pharmaceuticals (RCPI) in Q4 2015, closing a stake of 31,699 shares — an estimated $25K sold.

Geode Capital Management first reported a position in RCPI in Q2 2014 and held it in 5 quarters. The position peaked at $414K in Q2 2014. 8 funds tracked by Wall St. Rank hold RCPI as of Q4 2015.

  • Geode Capital Management reported no remaining Rock Creek Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Geode Capital Management sold 31,699 Rock Creek Pharmaceuticals shares in Q4 2015, an estimated $25K.
  • Geode Capital Management first reported a position in Rock Creek Pharmaceuticals in Q2 2014 and held it in 5 quarters.
  • Geode Capital Management's Rock Creek Pharmaceuticals position peaked at $414K in Q2 2014.
  • 8 funds tracked by Wall St. Rank held Rock Creek Pharmaceuticals as of Q4 2015.

Based on Geode Capital Management's 13F filing for Q4 2015, filed 12 Feb 2016.